Replies to post #2473 on Skye Bioscience Inc (SKYE)

[AntonChigurh]

Thanks CJ for keeping me Sharp

Appropriate patients were treated with either orally administered delta-9-tetrahydrocannabinol capsules or inhaled marijuana in addition to their existing therapeutic regimen.

This was in 2002

So what NMUS longs are speculating is that UM has developed a glaucoma candidate that can overcome the breakdown of efficacy caused by increased tolerance...



Note the date.

I like my side of the bet :)

GLTFA

DYODD